NCT03013296View on ClinicalTrials.gov

Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

September 30, 2018

Conditions
Glucose Metabolism Disorders
Interventions
OTHER

GIP-A

GIP-A

OTHER

Placebo

Placebo

OTHER

GLP-1 receptor antagonist Exendin[9-39]

Exendin\[9-39\]

OTHER

GIP-A + Exendin[9-39]

GIP-A + Exendin\[9-39\]

Trial Locations (1)

2900

Center for Diabetes Research, Copenhagen

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03013296 - Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4) | Biotech Hunter | Biotech Hunter